Focused on providing the latest in stem cell therapies for horses, the University of California, Davis, School of Veterinary Medicine has opened its new Regenerative Medicine Laboratory at the William R. Pritchard Veterinary Medical Teaching
Windpuffs are soft, fluid-filled swellings toward the back of the fetlock joint, resulting from inflamed deep digital flexor tendon sheaths. Most commonly, these puffy enlargements are symptomless blemishes–old and cold, the result of years of hard work.
One of the most common causes of lameness in horses–an injury to tendon and ligaments–can now be treated at Virginia Tech’s Marion duPont Scott Equine Medical Center, with one of the newest treatments available, platelet-rich plasma.
Motivated by a desire to help broaden the exploration of regenerative medicine as a treatment option for companion animals and horses, Dick and Carolyn Randall of Cupertino, Calif., provided core funding to launch a five-year, $2.5 million study
Regenerative medicine technology in humans and animals is advancing at a much faster pace than most of us realize. It has offered hope to thousands of humans suffering from diseases and injuries that destroy or damage vital cells. In animals,
Findings from the RVC indicate that stem cell therapy for superficial digital flexor tendon (SDFT) injury can significantly reduce the rate of re-injury over a three year period compared to conventionally treated horses.
Researchers from the United Kingdom recently embarked on an 18-month exercise study to determine why the equine superficial digital flexor tendon (SDFT) is more prone to injury than the various other tendons located in the distal (lower) part of
The Marion duPont Scott Equine Medical Center’s growing stature as a research enterprise has taken a significant step forward with the construction of a major new laboratory that is equipped to explore the molecular aspects of disease and trauma
After 69 starts, $2,977,130 in purses won, and nearly 80 miles of dirt and turf, the finish line for Evening Attire finally arrived last month with the announcement of his
The old warrior Evening Attire, a stakes-winning Thoroughbred racehorse at age 10 and earner of nearly $3 million, has been retired due to a suspensory injury, co-owners and breeders Tommy Kelly and Joseph and Mary Grant announced Sept. 28.
While not nearly as controversial as research involving embryonic-derived stem cells in human medicine, the veterinary world is certainly divided on the clinical benefits, or lack thereof, of bone marrow-derived stem cell therapy for tendon
Gary Tanaka’s Sudan, projected as the probable pace setter in the Arlington Million (gr. IT), was withdrawn from the race Aug. 8.
“He was fine when he galloped yesterday,” trainer Bobby Frankel said. “But when we scanned him this morning
Stem cell research has shown that adult stem cells can be safely and easily harvested from fat deposits in a horse and used to treat a variety of musculoskeletal diseases. These cells are capable of becoming bone, muscle, cartilage, or tendon cells.
Brass Hat has an injury that will keep him from training for the next three months, which means he could not race before 2009, even if all goes well. The 7-year-old gelded son of Prized suffered a strained suspensory ligament in his left leg.
Larry Bramlage, DVM, Dipl. ACVS, who in mid May said grade III winner Chelokee’s chances of survival were at 60-40 after the colt dislocated his right front ankle, is now talking about the colt being released from Rood & Riddle Equine
Grade I winners Nobiz like Shobiz and Panty Raid have been retired due to suspensory problems.
Stud plans are being decided for millionaire Nobiz Like Shobiz.
A 4-year-old son of Albert the Great, Nobiz Like Shobiz scored his big win in
Stay on top of the most recent Horse Health news with
